BLOG

A Systemic Solution for Systemic Problems: IV Stem Cell Therapy

Published 2026.09.29 7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

When health challenges are not isolated to a single joint or organ, finding a comprehensive approach can be difficult. You might experience discomfort in your knees, shoulders, and hands simultaneously, or deal with a sense of widespread, chronic inflammation that contributes to fatigue and slower recovery. Treating each area individually can feel like an endless cycle without addressing potential underlying, body-wide issues.

A Systemic Approach: IV Adipose Stem Cell Therapy

For individuals with concerns affecting multiple parts of the body, a systemic treatment that works throughout the bloodstream may be a consideration. IV adipose stem cell therapy is a form of regenerative medicine that uses your own cells to support your body’s natural repair and regulation processes. The treatment involves collecting a small amount of your fat tissue, from which mesenchymal stem cells (MSCs) are isolated and expanded in number at a specialized facility. These cultured cells are then returned to your body through an intravenous (IV) infusion.

By introducing the cells into the bloodstream, they can circulate throughout the body. This method is based on a biological mechanism known as the “homing effect,” where stem cells have been observed in studies to navigate towards sites of injury and inflammation. This potential for targeted, body-wide action is what makes IV infusion a consideration for those with multiple areas of concern, from multiple joint pain to broader anti-aging treatment goals.

The “Homing Effect”: How Stem Cells May Find Damaged Tissues

The principle behind the systemic use of IV-infused stem cell therapy is the “homing effect.” When tissues in the body are damaged or inflamed, they release specific chemical signals, such as cytokines and chemokines. These signals act as alerts, indicating that an area requires attention.

Mesenchymal stem cells have surface receptors that can recognize these signals. As the infused MSCs circulate, these receptors may allow them to detect the signals, exit the bloodstream, and migrate into the tissue where the inflammation or damage is located. Once at a target site, MSCs are reported to exert their influence in several ways:

Anti-inflammatory Action: They may release substances that help calm excessive inflammatory responses.
Trophic Support: They can secrete growth factors that encourage surrounding cells to repair and regenerate.
Immunomodulation: They may help balance the local immune environment, moderating overactive immune reactions that can contribute to chronic damage.

The homing ability is a subject of ongoing scientific research, with studies exploring how systemically delivered MSCs biodistribute and exert their effects in various conditions. It is this potential to autonomously target multiple problem areas that distinguishes the IV infusion method from local injections.

Systemic vs. Local: Why an IV Approach Might Be Considered

Stem cells can be administered in two primary ways: through local injection or systemic IV infusion. The choice of method depends on the patient’s condition and treatment goals, as determined by a physician.

Local injections are often used for a specific, well-defined problem area. For example, if a patient has osteoarthritis concentrated in a single knee, injecting stem cells directly into the joint allows for a high concentration of cells at the precise point of damage. This is a targeted approach for a localized issue.

Systemic IV infusion is considered for conditions that are more widespread. If a person suffers from pain in multiple joints, systemic inflammation, or is seeking treatment for general wellness and healthy aging, an IV infusion offers a way to potentially address these diffuse concerns. The circulating cells have the opportunity to home in on various sites of low-grade inflammation throughout the body. This makes it a potential strategy for tackling systemic problems and supporting long-term health.

What to Know Before Considering Treatment in Japan

When considering adipose stem cell therapy, it is essential to understand the context in which it is provided. This treatment is a form of private medical care and is not covered by Japanese public health insurance. The effects and outcomes can vary between individuals, and no treatment can guarantee a specific result. It is not a cure for any disease and should not be considered a replacement for standard medical care.

In Japan, regenerative medicine is regulated to ensure safety. Treatments like IV adipose stem cell therapy are provided under plans submitted to and accepted by the Ministry of Health, Labour and Welfare, in accordance with the Act on the Safety of Regenerative Medicine. This framework ensures that procedures, from cell collection to culturing and administration, adhere to established safety and quality standards.

A thorough consultation with a physician is a mandatory first step. During this consultation, the doctor will review your medical history, current health status, and treatment goals to determine if you are a suitable candidate. This is also your opportunity to receive a detailed explanation of the procedure, expected number of treatments, duration, potential risks, and side effects, as well as the full cost involved.

Learn More About Your Options in Osaka

Living with chronic, multi-site pain or systemic inflammation can be challenging, but developments in regenerative medicine are offering new perspectives for managing these complex conditions. The systemic approach of IV-infused adipose stem cell therapy, guided by the principle of the homing effect, offers a potential pathway for addressing widespread issues by utilizing the body’s own natural repair mechanisms.

At Grand Green Osaka Umekita Clinic, we provide consultations for patients interested in learning more about this type of treatment. If you are exploring options for multiple joint pain, systemic inflammation, or long-term health investment, we invite you to review our detailed information page. There, you can find more on the treatment flow, fees, and what to expect. A final decision on eligibility can only be made after a comprehensive evaluation by our physicians.

For more details on Adipose-Derived Stem Cell Therapy at our clinic in Osaka, please see our service page: Adipose-Derived Stem Cell Therapy | Grand Green Osaka Umekita Clinic.

IV Therapy vs. Local Injection

Local Injection

For a specific, single area
High cell dose at target site
e.g., One painful joint

Systemic IV

For widespread, multiple areas
Cells circulate to find targets
e.g., Multiple joints, wellness

This diagram is a conceptual summary of the article's content

Learn more about Adipose-Derived Stem Cell Therapy

References

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to Adipose-Derived Stem Cell Therapy ›